Giving Hope to metastatic cancer patients

Learn More
Groundbreaking mRNA therapies for metastatic cancer patients

Our First-in-Class mRNA therapies are designed to enhance the effectiveness of immunotherapies and target metastatic cancers.

Our Innovations

3 Patents

Protecting our core technology

Top Notch science

Pubished in Nature Cell Biology and Nature Cancer

100% survival vs 40% for ICI alone

In metastatic cancer preclinical models

+1m€

Raised so far in non-dilutive grants

What We Do

01.

First-in-Class and Innovative MoA

Our technology specifically increases the whole Antigen Presentation Machinery (APM)

Read More
02.

From “cold tumors” to “hot tumors”

Our patented technology turns immune‑resistant tumors into responsive tumors.

Read More
03.

Unlock new markets for immunotherapies

Our technology unlocks new immunotherapy markets for Big Pharma companies.

Read More

VIOLET Pharmaceuticals is a spin-off company from the Hospital del Mar Research Institute (HMRIB).

VIOLET Pharmaceuticals is accelerated by the prestigious Paris Saclay Cancer Cluster (PSCC).

Join Us to give hope to metastatic cancer patients

Learn More

Scroll to Top